Pulmonary Large Cell Neuroendocrine Carcinoma.


Journal

Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087

Informations de publication

Date de publication:
2022
Historique:
received: 23 07 2022
accepted: 29 09 2022
entrez: 28 10 2022
pubmed: 29 10 2022
medline: 1 11 2022
Statut: epublish

Résumé

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of malignant pulmonary tumor. The incidence rate of LCNEC was reported to be 0.3%-3% in lung cancers. Although LCNEC is classified as non-small cell lung cancer (NSCLC), it is more aggressive and malignant than other NSCLC, and its biological behavior is similar to that of small cell lung cancer (SCLC). Most of the LCNEC patients are elderly smoking male and the clinical manifestations are not specific. The imaging manifestations of the tumors are often located in the periphery and the upper lobes, and the enlargement of mediastinal or hilar lymph nodes is common. The diagnosis is mainly based on pathology by the histological features and immunohistochemistry (IHC). Specific neuroendocrine markers such as chromogranin A (CgA), synaptophysin (Syn) and CD56 are usually diffusely positive in LCNEC, and found that insulinoma-associated protein (INSM1) and high rate of Ki-67 are helpful for diagnosis. More differential diagnoses also increase the difficulty of correctly diagnosing LCNEC. The rise of LCNEC molecular typing in recent years may be helpful for diagnosis and subsequent treatment. This review focuses on the epidemiological features, imaging studies, pathology, diagnosis, treatment, and prognosis of LCNEC.

Identifiants

pubmed: 36304941
doi: 10.3389/pore.2022.1610730
pii: 1610730
pmc: PMC9592721
doi:

Substances chimiques

Biomarkers, Tumor 0
INSM1 protein, human 147955-03-1
Repressor Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610730

Informations de copyright

Copyright © 2022 Yang, Fan and Lu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Immunother Cancer. 2021 Feb;9(2):
pubmed: 33597218
Lung Cancer. 2015 Apr;88(1):70-3
pubmed: 25700797
Histopathology. 2014 Mar;64(4):547-56
pubmed: 24266897
Surg Pathol Clin. 2019 Dec;12(4):1055-1071
pubmed: 31672294
Turk J Med Sci. 2016 Dec 20;46(6):1808-1815
pubmed: 28081332
Eur Respir J. 2017 Oct 26;50(4):
pubmed: 29074547
Ann Oncol. 2010 Oct;21 Suppl 7:vii65-71
pubmed: 20943645
J Thorac Cardiovasc Surg. 1972 Sep;64(3):413-21
pubmed: 5054879
Lung Cancer. 2020 May;143:40-46
pubmed: 32203769
Hum Pathol. 2003 Feb;34(2):136-42
pubmed: 12612881
J Coll Physicians Surg Pak. 2018 Mar;28(3):240-242
pubmed: 29544586
J Thorac Oncol. 2020 Feb;15(2):231-247
pubmed: 31751681
J Clin Oncol. 2011 Dec 1;29(34):e819-22
pubmed: 22042963
Transl Lung Cancer Res. 2020 Jun;9(3):860-878
pubmed: 32676352
Oncol Res Treat. 2018;41(5):306-312
pubmed: 29742518
Ann Thorac Surg. 2011 Oct;92(4):1180-6; discussion 1186-7
pubmed: 21867986
Jpn J Clin Oncol. 2011 Jul;41(7):897-901
pubmed: 21636606
J Cancer Res Clin Oncol. 2015 Dec;141(12):2121-30
pubmed: 25963795
J Cancer. 2019 Oct 19;10(25):6422-6430
pubmed: 31772675
Hum Pathol. 2016 Feb;48:142-7
pubmed: 26596584
J Clin Oncol. 2006 Jan 1;24(1):70-6
pubmed: 16382115
Clin Cancer Res. 2017 Feb 1;23(3):757-765
pubmed: 27507618
Clin Imaging. 2007 Nov-Dec;31(6):379-84
pubmed: 17996599
Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2243-5
pubmed: 23250479
J Thorac Dis. 2017 Nov;9(Suppl 15):S1474-S1483
pubmed: 29201450
Sci Transl Med. 2015 Aug 26;7(302):302ra136
pubmed: 26311731
Ann Thorac Surg. 2000 Jul;70(1):258-63
pubmed: 10921719
Exp Ther Med. 2015 Jan;9(1):197-202
pubmed: 25452802
Lung Cancer. 2013 Mar;79(3):205-14
pubmed: 23312550
J Thorac Dis. 2017 Nov;9(Suppl 15):S1448-S1457
pubmed: 29201448
Gen Thorac Cardiovasc Surg. 2017 Nov;65(11):633-639
pubmed: 28766133
Ann Thorac Surg. 2007 Aug;84(2):702-7
pubmed: 17643676
J Thorac Cardiovasc Surg. 2005 Apr;129(4):819-24
pubmed: 15821649
J Thorac Oncol. 2014 Mar;9(3):273-84
pubmed: 24518085
Jpn J Clin Oncol. 2007 Jul;37(7):482-6
pubmed: 17652109
World J Surg. 2017 Jul;41(7):1820-1827
pubmed: 28204910
Thorac Cancer. 2020 Sep;11(9):2561-2569
pubmed: 32691982
Lung Cancer. 2014 Jun;84(3):254-8
pubmed: 24679951
Cancer. 2001 Jun 1;91(11):1992-2000
pubmed: 11391577
Am J Surg Pathol. 2020 Jun;44(6):757-764
pubmed: 32118626
Clin Cancer Res. 2016 Jul 15;22(14):3618-29
pubmed: 26960398
Histopathology. 2018 May;72(6):1067-1069
pubmed: 29274092
Eur J Cardiothorac Surg. 2013 Jan;43(1):111-4
pubmed: 22529187
Histopathology. 2010 Feb;56(3):356-63
pubmed: 20459535
Nat Genet. 2012 Oct;44(10):1104-10
pubmed: 22941188
Eur J Med Res. 2015 Aug 14;20:64
pubmed: 26272455
Semin Diagn Pathol. 2015 Nov;32(6):469-79
pubmed: 26561395
Hum Pathol. 2001 Sep;32(9):918-25
pubmed: 11567220
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
J Thorac Cardiovasc Surg. 2002 Aug;124(2):285-92
pubmed: 12167788
Front Oncol. 2021 Apr 22;11:671799
pubmed: 33968782
Lung Cancer. 2018 May;119:48-55
pubmed: 29656752
Histopathology. 2022 Aug;81(2):205-214
pubmed: 35544410
J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868
pubmed: 34340212
Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):206-10
pubmed: 17185180
J Clin Oncol. 2005 Dec 1;23(34):8774-85
pubmed: 16314638
Clin Cancer Res. 2018 Jan 1;24(1):33-42
pubmed: 29066508
J Thorac Imaging. 2001 Jul;16(3):156-62
pubmed: 11428414
Ann Thorac Surg. 2004 Apr;77(4):1163-7
pubmed: 15063227
Clin Cancer Res. 2015 Dec 15;21(24):5619-29
pubmed: 26246306
AJR Am J Roentgenol. 2004 Jan;182(1):87-91
pubmed: 14684518
Lung Cancer. 2012 Aug;77(2):365-70
pubmed: 22579297
J Thorac Oncol. 2015 Aug;10(8):1133-41
pubmed: 26039012
Am J Surg Pathol. 2021 Feb 1;45(2):147-159
pubmed: 33264139
Lung Cancer. 2006 Jul;53(1):111-5
pubmed: 16697073
Hum Pathol. 2000 Aug;31(8):980-7
pubmed: 10987260
J Thorac Oncol. 2011 Jun;6(6):1050-8
pubmed: 21566535
Nat Commun. 2018 Mar 13;9(1):1048
pubmed: 29535388
Clin Lung Cancer. 2016 Sep;17(5):e121-e129
pubmed: 26898325
Jpn J Clin Oncol. 2003 Jan;33(1):10-3
pubmed: 12604717
Eur J Radiol. 2015 Nov;84(11):2332-8
pubmed: 26279139
AJR Am J Roentgenol. 2007 May;188(5):1223-31
pubmed: 17449764
Oncology (Williston Park). 2009 Nov 30;23(13):1133-40
pubmed: 20043461
Am J Surg Pathol. 1991 Jun;15(6):529-53
pubmed: 1709558
Lung Cancer. 2017 Jun;108:115-120
pubmed: 28625622
Cancers (Basel). 2012 Jul 31;4(3):777-98
pubmed: 24213466
Rev Assoc Med Bras (1992). 2017 Oct;63(10):856-861
pubmed: 29267486
Int J Clin Oncol. 2014 Feb;19(1):63-7
pubmed: 23250620
Eur Respir J. 2016 Feb;47(2):615-24
pubmed: 26541538
Lung Cancer. 2022 Apr;166:161-169
pubmed: 35287068
Ann Thorac Surg. 2003 Feb;75(2):348-52
pubmed: 12607637
Ann Oncol. 2017 Aug 01;28(8):1898-1902
pubmed: 28535181
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
J Thorac Cardiovasc Surg. 2009 Aug;138(2):446-53
pubmed: 19619794
Mod Pathol. 2017 Jun;30(6):797-809
pubmed: 28256572
Zhonghua Yi Xue Za Zhi. 2022 Apr 12;102(14):1020-1027
pubmed: 35399022
Am J Surg Pathol. 2018 May;42(5):665-671
pubmed: 29438167
Am J Clin Pathol. 2020 Jan 2;153(2):165-174
pubmed: 31593583
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Thorac Surg Clin. 2014 Aug;24(3):257-66
pubmed: 25065926
J Thorac Oncol. 2022 Mar;17(3):362-387
pubmed: 34808341
Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6
pubmed: 22219429
Intern Med. 2018 Mar 1;57(5):713-716
pubmed: 29151522
Exp Ther Med. 2011 Nov;2(6):1041-1045
pubmed: 22977617
Am J Surg Pathol. 2019 Feb;43(2):211-219
pubmed: 30334830
ERJ Open Res. 2017 Mar 29;3(1):
pubmed: 28382303
Ann Thorac Surg. 2015 Mar;99(3):983-9
pubmed: 25596870
Endocr Relat Cancer. 2013 Dec 16;21(1):1-16
pubmed: 24344249
Cancer. 1996 Jun 1;77(11):2393-9
pubmed: 8635112
J Immunother Cancer. 2017 Sep 19;5(1):75
pubmed: 28923100
Endocr Relat Cancer. 2010 Oct 29;17(4):977-87
pubmed: 20817788
Gen Thorac Cardiovasc Surg. 2014 Jun;62(6):351-6
pubmed: 24719260
Clin Cancer Res. 2020 Feb 15;26(4):892-901
pubmed: 31694833
J Thorac Oncol. 2013 Jul;8(7):980-4
pubmed: 23774385

Auteurs

Lan Yang (L)

Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Department of Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, China.

Ying Fan (Y)

Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Department of Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, China.

Hongyang Lu (H)

Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Department of Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
The Second Clinical Medical College, Wenzhou Medical University, Wenzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH